Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy
Palabras clave : 
Carcinoma, Non-Small-Cell Lung/drug therapy
Combined Modality Therapy
Carcinoma, Non-Small-Cell Lung/genetics
Fecha de publicación: 
2013
Editorial : 
BioMed Central
ISSN: 
1479-5876
Cita: 
Castañon E, Bosch-Barrera J, López I, Collado V, Moreno M, López-Picazo JM et al. Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy. J Transl Med. 2013 Jan 11;11:13.
Resumen
A correlation between Id1 and Id3 protein expression is observed. Id1 and Id3 co-expression seems associated with a poor clinical outcome in patients with locally advanced NSCLC treated with definitive chemoradiotherapy.

Ficheros en este registro:
Fichero: 
J transl med 1479-5876-11-13.pdf
Descripción: 
Tamaño: 
932,58 kB
Formato: 
Adobe PDF


Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.